Global Cell Therapy and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029
The global Cell Therapy and Gene Therapy CDMO market size is expected to reach $ 10940 million by 2029, rising at a market growth of 19.1% CAGR during the forecast period (2023-2029).
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
This report studies the global Cell Therapy and Gene Therapy CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy and Gene Therapy CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy and Gene Therapy CDMO total market, 2018-2029, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Therapy and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)
Global Cell Therapy and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell Therapy and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec and He Yuan Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy and Gene Therapy CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Therapy and Gene Therapy CDMO Market, By Region:
1. How big is the global Cell Therapy and Gene Therapy CDMO market?
2. What is the demand of the global Cell Therapy and Gene Therapy CDMO market?
3. What is the year over year growth of the global Cell Therapy and Gene Therapy CDMO market?
4. What is the total value of the global Cell Therapy and Gene Therapy CDMO market?
5. Who are the major players in the global Cell Therapy and Gene Therapy CDMO market?
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
This report studies the global Cell Therapy and Gene Therapy CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy and Gene Therapy CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy and Gene Therapy CDMO total market, 2018-2029, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Therapy and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)
Global Cell Therapy and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Therapy and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell Therapy and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Pharmaceuticals, Thermo Fisher, catalent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, WuXi AppTec and He Yuan Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy and Gene Therapy CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Therapy and Gene Therapy CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cell Therapy
- Gene Therapy
- Clinical Stage Projects
- Commercialization Stage Projects
- Lonza Pharmaceuticals
- Thermo Fisher
- catalent
- Jubilant LifeSciences
- Boehringer Ingelheim
- Oxford BioMedica
- Charles River
- WuXi AppTec
- He Yuan Biology
- GenScript Biotech
- Kanglong Chemical
- Porton shares
- Sano Biologics
- Yunzhou Biology
1. How big is the global Cell Therapy and Gene Therapy CDMO market?
2. What is the demand of the global Cell Therapy and Gene Therapy CDMO market?
3. What is the year over year growth of the global Cell Therapy and Gene Therapy CDMO market?
4. What is the total value of the global Cell Therapy and Gene Therapy CDMO market?
5. Who are the major players in the global Cell Therapy and Gene Therapy CDMO market?
1 SUPPLY SUMMARY
1.1 Cell Therapy and Gene Therapy CDMO Introduction
1.2 World Cell Therapy and Gene Therapy CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Therapy and Gene Therapy CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.3 China Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.4 Europe Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.5 Japan Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.6 South Korea Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.7 ASEAN Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.8 India Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy and Gene Therapy CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy and Gene Therapy CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.2 World Cell Therapy and Gene Therapy CDMO Consumption Value by Region
2.2.1 World Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023)
2.2.2 World Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.4 China Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.5 Europe Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.6 Japan Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.7 South Korea Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.8 ASEAN Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.9 India Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
3 WORLD CELL THERAPY AND GENE THERAPY CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy and Gene Therapy CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy and Gene Therapy CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy and Gene Therapy CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy and Gene Therapy CDMO in 2022
3.3 Cell Therapy and Gene Therapy CDMO Company Evaluation Quadrant
3.4 Cell Therapy and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy and Gene Therapy CDMO Market: Region Footprint
3.4.2 Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
3.4.3 Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy and Gene Therapy CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Therapy and Gene Therapy CDMO Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Therapy and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
4.4 China Based Companies Cell Therapy and Gene Therapy CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Therapy and Gene Therapy CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
4.5 Rest of World Based Cell Therapy and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy and Gene Therapy CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Gene Therapy
5.3 Market Segment by Type
5.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3.2 World Cell Therapy and Gene Therapy CDMO Market Size by Type (2024-2029)
5.3.3 World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Therapy and Gene Therapy CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Stage Projects
6.2.2 Commercialization Stage Projects
6.3 Market Segment by Application
6.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2024-2029)
6.3.3 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza Pharmaceuticals
7.1.1 Lonza Pharmaceuticals Details
7.1.2 Lonza Pharmaceuticals Major Business
7.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Services
7.1.4 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Pharmaceuticals Recent Developments/Updates
7.1.6 Lonza Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Services
7.2.4 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 catalent
7.3.1 catalent Details
7.3.2 catalent Major Business
7.3.3 catalent Cell Therapy and Gene Therapy CDMO Product and Services
7.3.4 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 catalent Recent Developments/Updates
7.3.6 catalent Competitive Strengths & Weaknesses
7.4 Jubilant LifeSciences
7.4.1 Jubilant LifeSciences Details
7.4.2 Jubilant LifeSciences Major Business
7.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Services
7.4.4 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Jubilant LifeSciences Recent Developments/Updates
7.4.6 Jubilant LifeSciences Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Services
7.5.4 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 Oxford BioMedica
7.6.1 Oxford BioMedica Details
7.6.2 Oxford BioMedica Major Business
7.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Services
7.6.4 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Oxford BioMedica Recent Developments/Updates
7.6.6 Oxford BioMedica Competitive Strengths & Weaknesses
7.7 Charles River
7.7.1 Charles River Details
7.7.2 Charles River Major Business
7.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product and Services
7.7.4 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Charles River Recent Developments/Updates
7.7.6 Charles River Competitive Strengths & Weaknesses
7.8 WuXi AppTec
7.8.1 WuXi AppTec Details
7.8.2 WuXi AppTec Major Business
7.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Services
7.8.4 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 WuXi AppTec Recent Developments/Updates
7.8.6 WuXi AppTec Competitive Strengths & Weaknesses
7.9 He Yuan Biology
7.9.1 He Yuan Biology Details
7.9.2 He Yuan Biology Major Business
7.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Services
7.9.4 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 He Yuan Biology Recent Developments/Updates
7.9.6 He Yuan Biology Competitive Strengths & Weaknesses
7.10 GenScript Biotech
7.10.1 GenScript Biotech Details
7.10.2 GenScript Biotech Major Business
7.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Services
7.10.4 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 GenScript Biotech Recent Developments/Updates
7.10.6 GenScript Biotech Competitive Strengths & Weaknesses
7.11 Kanglong Chemical
7.11.1 Kanglong Chemical Details
7.11.2 Kanglong Chemical Major Business
7.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Services
7.11.4 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Kanglong Chemical Recent Developments/Updates
7.11.6 Kanglong Chemical Competitive Strengths & Weaknesses
7.12 Porton shares
7.12.1 Porton shares Details
7.12.2 Porton shares Major Business
7.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product and Services
7.12.4 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Porton shares Recent Developments/Updates
7.12.6 Porton shares Competitive Strengths & Weaknesses
7.13 Sano Biologics
7.13.1 Sano Biologics Details
7.13.2 Sano Biologics Major Business
7.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Services
7.13.4 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sano Biologics Recent Developments/Updates
7.13.6 Sano Biologics Competitive Strengths & Weaknesses
7.14 Yunzhou Biology
7.14.1 Yunzhou Biology Details
7.14.2 Yunzhou Biology Major Business
7.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Services
7.14.4 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Yunzhou Biology Recent Developments/Updates
7.14.6 Yunzhou Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Therapy and Gene Therapy CDMO Industry Chain
8.2 Cell Therapy and Gene Therapy CDMO Upstream Analysis
8.3 Cell Therapy and Gene Therapy CDMO Midstream Analysis
8.4 Cell Therapy and Gene Therapy CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell Therapy and Gene Therapy CDMO Introduction
1.2 World Cell Therapy and Gene Therapy CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Therapy and Gene Therapy CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.3 China Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.4 Europe Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.5 Japan Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.6 South Korea Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.7 ASEAN Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.3.8 India Cell Therapy and Gene Therapy CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy and Gene Therapy CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy and Gene Therapy CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.2 World Cell Therapy and Gene Therapy CDMO Consumption Value by Region
2.2.1 World Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023)
2.2.2 World Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.4 China Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.5 Europe Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.6 Japan Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.7 South Korea Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.8 ASEAN Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
2.9 India Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029)
3 WORLD CELL THERAPY AND GENE THERAPY CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy and Gene Therapy CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy and Gene Therapy CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy and Gene Therapy CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy and Gene Therapy CDMO in 2022
3.3 Cell Therapy and Gene Therapy CDMO Company Evaluation Quadrant
3.4 Cell Therapy and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy and Gene Therapy CDMO Market: Region Footprint
3.4.2 Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
3.4.3 Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy and Gene Therapy CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Therapy and Gene Therapy CDMO Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Therapy and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
4.4 China Based Companies Cell Therapy and Gene Therapy CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Therapy and Gene Therapy CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
4.5 Rest of World Based Cell Therapy and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy and Gene Therapy CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Gene Therapy
5.3 Market Segment by Type
5.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3.2 World Cell Therapy and Gene Therapy CDMO Market Size by Type (2024-2029)
5.3.3 World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Therapy and Gene Therapy CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Stage Projects
6.2.2 Commercialization Stage Projects
6.3 Market Segment by Application
6.3.1 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2024-2029)
6.3.3 World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza Pharmaceuticals
7.1.1 Lonza Pharmaceuticals Details
7.1.2 Lonza Pharmaceuticals Major Business
7.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Services
7.1.4 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Pharmaceuticals Recent Developments/Updates
7.1.6 Lonza Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Services
7.2.4 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 catalent
7.3.1 catalent Details
7.3.2 catalent Major Business
7.3.3 catalent Cell Therapy and Gene Therapy CDMO Product and Services
7.3.4 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 catalent Recent Developments/Updates
7.3.6 catalent Competitive Strengths & Weaknesses
7.4 Jubilant LifeSciences
7.4.1 Jubilant LifeSciences Details
7.4.2 Jubilant LifeSciences Major Business
7.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Services
7.4.4 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Jubilant LifeSciences Recent Developments/Updates
7.4.6 Jubilant LifeSciences Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Services
7.5.4 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 Oxford BioMedica
7.6.1 Oxford BioMedica Details
7.6.2 Oxford BioMedica Major Business
7.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Services
7.6.4 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Oxford BioMedica Recent Developments/Updates
7.6.6 Oxford BioMedica Competitive Strengths & Weaknesses
7.7 Charles River
7.7.1 Charles River Details
7.7.2 Charles River Major Business
7.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product and Services
7.7.4 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Charles River Recent Developments/Updates
7.7.6 Charles River Competitive Strengths & Weaknesses
7.8 WuXi AppTec
7.8.1 WuXi AppTec Details
7.8.2 WuXi AppTec Major Business
7.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Services
7.8.4 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 WuXi AppTec Recent Developments/Updates
7.8.6 WuXi AppTec Competitive Strengths & Weaknesses
7.9 He Yuan Biology
7.9.1 He Yuan Biology Details
7.9.2 He Yuan Biology Major Business
7.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Services
7.9.4 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 He Yuan Biology Recent Developments/Updates
7.9.6 He Yuan Biology Competitive Strengths & Weaknesses
7.10 GenScript Biotech
7.10.1 GenScript Biotech Details
7.10.2 GenScript Biotech Major Business
7.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Services
7.10.4 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 GenScript Biotech Recent Developments/Updates
7.10.6 GenScript Biotech Competitive Strengths & Weaknesses
7.11 Kanglong Chemical
7.11.1 Kanglong Chemical Details
7.11.2 Kanglong Chemical Major Business
7.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Services
7.11.4 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Kanglong Chemical Recent Developments/Updates
7.11.6 Kanglong Chemical Competitive Strengths & Weaknesses
7.12 Porton shares
7.12.1 Porton shares Details
7.12.2 Porton shares Major Business
7.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product and Services
7.12.4 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Porton shares Recent Developments/Updates
7.12.6 Porton shares Competitive Strengths & Weaknesses
7.13 Sano Biologics
7.13.1 Sano Biologics Details
7.13.2 Sano Biologics Major Business
7.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Services
7.13.4 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sano Biologics Recent Developments/Updates
7.13.6 Sano Biologics Competitive Strengths & Weaknesses
7.14 Yunzhou Biology
7.14.1 Yunzhou Biology Details
7.14.2 Yunzhou Biology Major Business
7.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Services
7.14.4 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Yunzhou Biology Recent Developments/Updates
7.14.6 Yunzhou Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Therapy and Gene Therapy CDMO Industry Chain
8.2 Cell Therapy and Gene Therapy CDMO Upstream Analysis
8.3 Cell Therapy and Gene Therapy CDMO Midstream Analysis
8.4 Cell Therapy and Gene Therapy CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy and Gene Therapy CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Therapy and Gene Therapy CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy and Gene Therapy CDMO Players in 2022
Table 12. World Cell Therapy and Gene Therapy CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Therapy and Gene Therapy CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy and Gene Therapy CDMO Player
Table 15. Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
Table 16. Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
Table 17. Cell Therapy and Gene Therapy CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy and Gene Therapy CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Therapy and Gene Therapy CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 23. China Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 29. World Cell Therapy and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Therapy and Gene Therapy CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Therapy and Gene Therapy CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Therapy and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Therapy and Gene Therapy CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Lonza Pharmaceuticals Major Business
Table 37. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Services
Table 38. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Pharmaceuticals Recent Developments/Updates
Table 40. Lonza Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Services
Table 44. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. catalent Basic Information, Area Served and Competitors
Table 48. catalent Major Business
Table 49. catalent Cell Therapy and Gene Therapy CDMO Product and Services
Table 50. catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. catalent Recent Developments/Updates
Table 52. catalent Competitive Strengths & Weaknesses
Table 53. Jubilant LifeSciences Basic Information, Area Served and Competitors
Table 54. Jubilant LifeSciences Major Business
Table 55. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Services
Table 56. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Jubilant LifeSciences Recent Developments/Updates
Table 58. Jubilant LifeSciences Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Services
Table 62. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 65. Oxford BioMedica Basic Information, Area Served and Competitors
Table 66. Oxford BioMedica Major Business
Table 67. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Services
Table 68. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Oxford BioMedica Recent Developments/Updates
Table 70. Oxford BioMedica Competitive Strengths & Weaknesses
Table 71. Charles River Basic Information, Area Served and Competitors
Table 72. Charles River Major Business
Table 73. Charles River Cell Therapy and Gene Therapy CDMO Product and Services
Table 74. Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Charles River Recent Developments/Updates
Table 76. Charles River Competitive Strengths & Weaknesses
Table 77. WuXi AppTec Basic Information, Area Served and Competitors
Table 78. WuXi AppTec Major Business
Table 79. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Services
Table 80. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. WuXi AppTec Recent Developments/Updates
Table 82. WuXi AppTec Competitive Strengths & Weaknesses
Table 83. He Yuan Biology Basic Information, Area Served and Competitors
Table 84. He Yuan Biology Major Business
Table 85. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Services
Table 86. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. He Yuan Biology Recent Developments/Updates
Table 88. He Yuan Biology Competitive Strengths & Weaknesses
Table 89. GenScript Biotech Basic Information, Area Served and Competitors
Table 90. GenScript Biotech Major Business
Table 91. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Services
Table 92. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. GenScript Biotech Recent Developments/Updates
Table 94. GenScript Biotech Competitive Strengths & Weaknesses
Table 95. Kanglong Chemical Basic Information, Area Served and Competitors
Table 96. Kanglong Chemical Major Business
Table 97. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Services
Table 98. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Kanglong Chemical Recent Developments/Updates
Table 100. Kanglong Chemical Competitive Strengths & Weaknesses
Table 101. Porton shares Basic Information, Area Served and Competitors
Table 102. Porton shares Major Business
Table 103. Porton shares Cell Therapy and Gene Therapy CDMO Product and Services
Table 104. Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Porton shares Recent Developments/Updates
Table 106. Porton shares Competitive Strengths & Weaknesses
Table 107. Sano Biologics Basic Information, Area Served and Competitors
Table 108. Sano Biologics Major Business
Table 109. Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Services
Table 110. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sano Biologics Recent Developments/Updates
Table 112. Yunzhou Biology Basic Information, Area Served and Competitors
Table 113. Yunzhou Biology Major Business
Table 114. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Services
Table 115. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Cell Therapy and Gene Therapy CDMO Upstream (Raw Materials)
Table 117. Cell Therapy and Gene Therapy CDMO Typical Customers
LIST OF FIGURE
Figure 1. Cell Therapy and Gene Therapy CDMO Picture
Figure 2. World Cell Therapy and Gene Therapy CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy and Gene Therapy CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Cell Therapy and Gene Therapy CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy and Gene Therapy CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy and Gene Therapy CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy and Gene Therapy CDMO Markets in 2022
Figure 27. United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Therapy and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 31. Cell Therapy
Figure 32. Gene Therapy
Figure 33. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Cell Therapy and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 36. Clinical Stage Projects
Figure 37. Commercialization Stage Projects
Figure 38. Cell Therapy and Gene Therapy CDMO Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Table 1. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy and Gene Therapy CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy and Gene Therapy CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Therapy and Gene Therapy CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy and Gene Therapy CDMO Players in 2022
Table 12. World Cell Therapy and Gene Therapy CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Therapy and Gene Therapy CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy and Gene Therapy CDMO Player
Table 15. Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
Table 16. Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
Table 17. Cell Therapy and Gene Therapy CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy and Gene Therapy CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Therapy and Gene Therapy CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 23. China Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Therapy and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 29. World Cell Therapy and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Therapy and Gene Therapy CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Therapy and Gene Therapy CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Therapy and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Therapy and Gene Therapy CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Therapy and Gene Therapy CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Lonza Pharmaceuticals Major Business
Table 37. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Services
Table 38. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Pharmaceuticals Recent Developments/Updates
Table 40. Lonza Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Services
Table 44. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. catalent Basic Information, Area Served and Competitors
Table 48. catalent Major Business
Table 49. catalent Cell Therapy and Gene Therapy CDMO Product and Services
Table 50. catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. catalent Recent Developments/Updates
Table 52. catalent Competitive Strengths & Weaknesses
Table 53. Jubilant LifeSciences Basic Information, Area Served and Competitors
Table 54. Jubilant LifeSciences Major Business
Table 55. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Services
Table 56. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Jubilant LifeSciences Recent Developments/Updates
Table 58. Jubilant LifeSciences Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Services
Table 62. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 65. Oxford BioMedica Basic Information, Area Served and Competitors
Table 66. Oxford BioMedica Major Business
Table 67. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Services
Table 68. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Oxford BioMedica Recent Developments/Updates
Table 70. Oxford BioMedica Competitive Strengths & Weaknesses
Table 71. Charles River Basic Information, Area Served and Competitors
Table 72. Charles River Major Business
Table 73. Charles River Cell Therapy and Gene Therapy CDMO Product and Services
Table 74. Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Charles River Recent Developments/Updates
Table 76. Charles River Competitive Strengths & Weaknesses
Table 77. WuXi AppTec Basic Information, Area Served and Competitors
Table 78. WuXi AppTec Major Business
Table 79. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Services
Table 80. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. WuXi AppTec Recent Developments/Updates
Table 82. WuXi AppTec Competitive Strengths & Weaknesses
Table 83. He Yuan Biology Basic Information, Area Served and Competitors
Table 84. He Yuan Biology Major Business
Table 85. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Services
Table 86. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. He Yuan Biology Recent Developments/Updates
Table 88. He Yuan Biology Competitive Strengths & Weaknesses
Table 89. GenScript Biotech Basic Information, Area Served and Competitors
Table 90. GenScript Biotech Major Business
Table 91. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Services
Table 92. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. GenScript Biotech Recent Developments/Updates
Table 94. GenScript Biotech Competitive Strengths & Weaknesses
Table 95. Kanglong Chemical Basic Information, Area Served and Competitors
Table 96. Kanglong Chemical Major Business
Table 97. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Services
Table 98. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Kanglong Chemical Recent Developments/Updates
Table 100. Kanglong Chemical Competitive Strengths & Weaknesses
Table 101. Porton shares Basic Information, Area Served and Competitors
Table 102. Porton shares Major Business
Table 103. Porton shares Cell Therapy and Gene Therapy CDMO Product and Services
Table 104. Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Porton shares Recent Developments/Updates
Table 106. Porton shares Competitive Strengths & Weaknesses
Table 107. Sano Biologics Basic Information, Area Served and Competitors
Table 108. Sano Biologics Major Business
Table 109. Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Services
Table 110. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sano Biologics Recent Developments/Updates
Table 112. Yunzhou Biology Basic Information, Area Served and Competitors
Table 113. Yunzhou Biology Major Business
Table 114. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Services
Table 115. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Cell Therapy and Gene Therapy CDMO Upstream (Raw Materials)
Table 117. Cell Therapy and Gene Therapy CDMO Typical Customers
LIST OF FIGURE
Figure 1. Cell Therapy and Gene Therapy CDMO Picture
Figure 2. World Cell Therapy and Gene Therapy CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy and Gene Therapy CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Therapy and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Cell Therapy and Gene Therapy CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy and Gene Therapy CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy and Gene Therapy CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy and Gene Therapy CDMO Markets in 2022
Figure 27. United States VS China: Cell Therapy and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Therapy and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 31. Cell Therapy
Figure 32. Gene Therapy
Figure 33. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Cell Therapy and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 36. Clinical Stage Projects
Figure 37. Commercialization Stage Projects
Figure 38. Cell Therapy and Gene Therapy CDMO Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
